AA
EWTX icon

ALPS Advisors’s Edgewise Therapeutics EWTX Stock Holding History

ALPS Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Buy
108,795
+21,469
+25% +$740K 0.02% 309
2026
Q1 		$2.75M Buy
87,326
+397
+0.5% +$11.4K 0.01% 352
2025
Q4 		$2.16M Buy
86,929
+35,817
+70% +$719K 0.01% 382
2025
Q3 		$829K Sell
51,112
-5,686
-10% -$80.7K ﹤0.01% 589
2025
Q2 		$745K Sell
56,798
-11,177
-16% -$161K ﹤0.01% 577
2025
Q1 		$1.5M Sell
67,975
-8,592
-11% -$225K 0.01% 392
2024
Q4 		$2.04M Buy
76,567
+7,661
+11% +$244K 0.01% 348
2024
Q3 		$1.84M Sell
68,906
-3,937
-5% -$78.3K 0.01% 372
2024
Q2 		$1.31M Buy
72,843
+7,171
+11% +$125K 0.01% 408
2024
Q1 		$1.2M Buy
65,672
+22,446
+52% +$357K 0.01% 430
2023
Q4 		$473K Sell
43,226
-3,648
-8% -$25.6K ﹤0.01% 614
2023
Q3 		$269K Buy
46,874
+361
+0.8% +$2.45K ﹤0.01% 903
2023
Q2 		$360K Buy
46,513
+4,834
+12% +$40.8K ﹤0.01% 703
2023
Q1 		$278K Sell
41,679
-1,227
-3% -$11.4K ﹤0.01% 945
2022
Q4 		$384K Buy
+42,906
New +$402K ﹤0.01% 690

Other funds holding EWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

ALPS Advisors's EWTX Position: Q2 2026 in Review

ALPS Advisors increased its Edgewise Therapeutics (EWTX) stake by 25% in Q2 2026, buying an estimated $740K and bringing the position to 108,795 shares worth $4.42M. The position accounts for 0.02% of the portfolio, ranked #309.

ALPS Advisors first reported a position in EWTX in Q4 2022 and has held it in 15 quarters since. 64 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • ALPS Advisors held 108,795 shares of Edgewise Therapeutics worth $4.42M as of Q2 2026.
  • ALPS Advisors bought 21,469 Edgewise Therapeutics shares in Q2 2026, an estimated $740K.
  • Edgewise Therapeutics made up 0.02% of ALPS Advisors's portfolio in Q2 2026, its #309 holding.
  • ALPS Advisors first reported a position in Edgewise Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 64 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.